Patents by Inventor Vitaly Pavlovich ZUBOV

Vitaly Pavlovich ZUBOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composite material for the X-ray contrast imaging of non-X-ray contrast implants
    Patent number: 10617797
    Abstract: The invention relates to the field of biotechnology and medicine, more precisely, to manufacturing technique of implantable medical devices (stents) containing organic lanthanum compound-based X-ray contrast agents distributed within the coating. The objective of this invention is the development of a biocompatible (and biodegradable) polymeric coating with glycolane on the surface of polymeric biodegradable vascular stents and other polymeric implants, which ensures, by means of introduction into a stent, satisfactory radiopacity both during stent installation in a patient and after installation, with a simultaneous additional positive effect provided by therapeutic properties of glycolane.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: April 14, 2020
    Assignee: LIMITED LIABILITY COMPANY “BIOSTEN”
    Inventors: Alla Nikolaevna Generalova, Anna Igorevna Prostyakova, Igor Ivanovich Pashkin, Vitaly Pavlovich Zubov, Dmitry Valeryevich Kapustin
  • COMPOSITE MATERIAL FOR THE X-RAY CONTRAST IMAGING OF NON-X-RAY CONTRAST IMPLANTS
    Publication number: 20180185554
    Abstract: The invention relates to the field of biotechnology and medicine, more precisely, to manufacturing technique of implantable medical devices (stents) containing organic lanthanum compound-based X-ray contrast agents distributed within the coating. The objective of this invention is the development of a biocompatible (and biodegradable) polymeric coating with glycolane on the surface of polymeric biodegradable vascular stents and other polymeric implants, which ensures, by means of introduction into a stent, satisfactory radiopacity both during stent installation in a patient and after installation, with a simultaneous additional positive effect provided by therapeutic properties of glycolane.
    Type: Application
    Filed: December 18, 2015
    Publication date: July 5, 2018
    Inventors: Alla Nikolaevna GENERALOVA, Anna Igorevna PROSTYAKOVA, Igor Ivanovich PASHKIN, Vitaly Pavlovich ZUBOV, Dmitry Valeryevich KAPUSTIN